ICON plc

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. ICON plc is a clinical research organization serving pharmaceutical, biotechnology, and medical device companies as well as government and public health organizations.

We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas. Its offerings include cardiac safety solutions, early clinical and bioanalytical services, specialty laboratory services for precision medicine, market access and reimbursement expertise, and manufacturing and pharmacy services covering small batch formulation, labeling, and distribution for clinical trials. The company also provides full service outsourcing and flexible support for biotech companies, including small and mid-sized firms, with services such as due diligence and asset valuation.

ICON offers decentralized and hybrid clinical trial solutions, site networks, and in-home clinical services aimed at patient recruitment and retention. Its Orbis platform connects human expertise, data, and AI across the clinical trial lifecycle. The ICON Cares program covers the company's environmental, social, and governance efforts.